Browsing Category

64217 posts
SUMSEI Triumphs at CES 2024, Solidifying Its Position as a Premier Home Appliance Brand Redefining the Intersection of Nature and Technology

SUMSEI Triumphs at CES 2024, Solidifying Its Position as a Premier Home Appliance Brand Redefining the Intersection of Nature and Technology

Sensory Engagement: An Immersive Experiential Booth Articulating the Brand Philosophy of ‘Nature,…
Daekyo Unveils ELIS Kindergarten: A Premium International Educational Hub in Thao Dien, Vietnam

Daekyo Unveils ELIS Kindergarten: A Premium International Educational Hub in Thao Dien, Vietnam

HO CHI MINH, Vietnam, Jan. 24, 2024 /PRNewswire/ — The education company…
Sciwind Biosciences Announces Positive Results from Phase 1 Clinical Trial of XW004, an Oral Formulation of Long-acting GLP-1 Analog Ecnoglutide

Sciwind Biosciences Announces Positive Results from Phase 1 Clinical Trial of XW004, an Oral Formulation of Long-acting GLP-1 Analog Ecnoglutide

Oral ecnoglutide was safe and well tolerated with gastrointestinal side effects as the…
Citibank Enhances Debit Card Benefits for Top-Tier Clients and is First Bank in Singapore to Partner Mastercard in Tree Restoration Initiative

Citibank Enhances Debit Card Benefits for Top-Tier Clients and is First Bank in Singapore to Partner Mastercard in Tree Restoration Initiative

Bank launches Citigold Private Client World Elite Debit Mastercard and joins Mastercard Priceless…
HELLO CYCLING Introduces 'LIQUID eKYC' for Age Verification of Specific Small Motorized Bicycles 'Electric Cycles' Available for Use

HELLO CYCLING Introduces 'LIQUID eKYC' for Age Verification of Specific Small Motorized Bicycles 'Electric Cycles' Available for Use

Instant access for users through automatic screening, also compatible with overseas passports…
PharmAbcine Announces First Patient Dosed in Phase 1a/b Clinical Trial of PMC-309 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced or Metastatic Solid Tumors

PharmAbcine Announces First Patient Dosed in Phase 1a/b Clinical Trial of PMC-309 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced or Metastatic Solid Tumors

Initiation of Phase 1a/b clinical trial exploring MTD, RP2D, safety and tolerability…
CDNetworks Successfully Mitigated a Blockchain DDoS Attack, Peaking at 1.025 Tbps, on the Eve of Bitcoin ETF Approval

CDNetworks Successfully Mitigated a Blockchain DDoS Attack, Peaking at 1.025 Tbps, on the Eve of Bitcoin ETF Approval

SINGAPORE, Jan. 24, 2024 /PRNewswire/ — CDNetworks, the APAC-leading network to deliver…
Top Singapore sustainability technology company SGP Foods advocates sustainability and carbon crediting for food production and the environment

Top Singapore sustainability technology company SGP Foods advocates sustainability and carbon crediting for food production and the environment

SINGAPORE, Jan. 24, 2024 /PRNewswire/ — With its innovative technologies, SGP Foods is…